CIS Pharma is the older company (2021 vs 1952); ARTBIO is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | ARTBIO | CIS Pharma |
|---|---|---|
| Founded | ||
| Founded | 2021 | 1952 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Switzerland |
| Employees | ||
| Employees | 74 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Fashion, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Not tracked yet |
| Total Funding | ||
| Total Funding | $245.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 3 | Not tracked yet |
| Services | ||
| Services | Development of Alpha Radioligand Therapies, Clinical Research and Trials, Manufacturing Ecosystem for Therapy Solutions | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Alpha Radioligand Therapies, Radiopharmaceuticals, Clinical-stage, Cancer Care, Precision Medicine, Pb-212 Isotope Technology, Therapeutic Development, Oncology, Innovative Medicine, Patient-centered Care, Isotope Supply Chain, Radioligand Ecosystem | Biopharmaceutical, Cancer Treatment, Immunotherapy, Next-generation Drugs, Targeted Therapies, Radioligand Therapy, Precision Medicine, ADCs, Bioconjugates, Radionuclide Therapy, Polymer Carriers, Innovative Drug Delivery, Precision Combination Therapies |
| Website | ||
| Website | artbio.com | cis-pharma.com |
About ARTBIO
ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope technology, aiming to offer transformative solutions in oncology. The company’s mantra, “Channeling...
About CIS Pharma
CIS Pharma is a biopharmaceutical company based in the Basel Area, Switzerland. Specializing in the development of next-gen immuno-conjugates, ADCs, and radioligand treatments, the company targets cancer patients with poor prognosis and a high spread of metastases. With assets including two targetin...
We will tell you when either one moves
BounceWatch watches ARTBIO and CIS Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ARTBIO and CIS Pharma — by email.
Frequently Asked Questions
Compare ARTBIO with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ARTBIO on 9 Jun 2026, and CIS Pharma on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.